Define
Enter your company website. Our planned onboarding flow identifies possible services and capabilities for you to review, correct and refine alongside your ideal customer profile.
Tell FG Intelligence what your business offers. We’re building a platform to connect your capabilities with drug-development activity and explain which companies could be commercially relevant — with the scientific evidence behind each potential match.
Your capabilities → programme evidence → potential service fit
Commercial teams know what they sell. But identifying which drug developers could need those capabilities means translating complex scientific activity into potential service demand.
That work often means switching between clinical records, company information and scientific sources — then manually deciding which accounts are worth pursuing.
Our planned workflow starts with your company, not a blank search screen. Website-assisted onboarding and matching are in development.
Enter your company website. Our planned onboarding flow identifies possible services and capabilities for you to review, correct and refine alongside your ideal customer profile.
Connect your confirmed capabilities with scientific programmes, development activity and organisations to surface potential service-fit opportunities.
Review a focused company list with reasons for each match, traceable supporting evidence and clear distinctions between observed facts and inferred needs.
Designed around the commercial questions faced by organisations supporting drug discovery and development.
FG Intelligence is in active development, initially focused on ADCs. Register your interest to hear about progress, product previews and opportunities to help shape the service-to-opportunity workflow.
We're inviting life sciences commercial professionals to follow the build.
script.js before inviting signups.